Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline

Grassi, Luigi; Caruso, Rosangela; Riba, Michelle; Lloyd‐Williams, Mari; Kissane, David W.; Rodin, Gary; McFarland, Daniel C.; Campos-Ródenas, R.; Zachariae, Robert; Santini, Daniele; Ripamonti, Carla

doi:10.1016/j.esmoop.2023.101155

Cited by 31 publications

(19 citation statements)

References 122 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This was underlined by a study in which 73% of the cancer patients remained untreated for their depression, merely 24% received an antidepressant and only 5% were seen by a mental health specialists ( Walker et al., 2014 ). This year a European Society for Medical Oncology (ESMO) clinical practice guideline for anxiety and depression in adult cancer patients was published ( Grassi et al., 2023 ). It is recommend to regularly screen for psychological symptoms.…”

Section: Discussionmentioning

confidence: 99%

“…Thus, when scored above the cut-off value, clinicians and oncology nurses should follow up on this and refer patients for a more formal assessment by a trained expert in psychology, to determine if specialized help or psychological treatment is required. If indicated, patients could benefit from psychoeducation, supportive therapy, cognitive-behavioral therapy, relaxation training, mindfulness-based therapy, or treatment with antidepressants ( Carbajal-López et al., 2022 ; Grassi et al., 2023 ; Lyu et al., 2022 ). As around half of the patients declines specialized help, and only one in four patients accepts referrals to psychological care ( Tondorf et al., 2018 ), there is still a lot to be gained.…”

Section: Discussionmentioning

confidence: 99%

“…Psychological symptoms that cancer patients may experience vary from concerns, worries, sense of uncertainty, sadness and feelings of hopelessness, to specific psychiatric anxiety and depressive disorders ( American Psychiatric Association & Association, 2013 ). Anxiety and depression are two of the most common psychological conditions, and fear of cancer progression (FCR) in cancer patients during active treatment and fear of cancer recurrence (FCR) in cancer survivors are common cancer-specific anxiety-related conditions ( Grassi et al., 2023 ). In previous studies, experiencing anxiety, depression or FCR was associated with a diminished health-related quality of life (HRQoL), higher symptom burden (e.g., pain or nausea), poor treatment adherence, poorer prognosis and higher mortality ( Arrieta et al., 2013 ; Carbajal-López et al., 2022 ; X.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study

van de Wal,

den Hollander,

Desar

et al. 2024

International Journal of Clinical and Health Psychology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study

van de Wal,

den Hollander,

Desar

et al. 2024

International Journal of Clinical and Health Psychology

View full text Add to dashboard Cite

“…Women with lung cancer demonstrated the highest prevalence rate of depression, with 24.7%, compared to other cancers [ 50 ]. A series of recommendations have been distributed in cancer settings for routine active screening for distress among patients [ 51 ]. However, less than half of patients with advanced lung cancer with anxiety or depressive symptoms received mental health care [ 52 , 53 ].…”

Section: Discussionmentioning

confidence: 99%

Lung Cancer in Women—Sociodemographic, Clinical and Psychological Characteristics with Comparison to Men

Trojnar,

Knetki-Wróblewska,

Sobieraj

et al. 2024

JCM

View full text Add to dashboard Cite

(1) Background: There is a difference in the course of lung cancer between women and men. Therefore, there is a need to evaluate various factors in the patient population treated in daily practice. The purpose of this study was to analyze the clinical, sociodemographic and psychological aspects of female lung cancer. To better express the results, we compared women and men. (2) Methods: Consecutive patients with a history of lung cancer treatment admitted to the outpatient oncology clinic (Department of Lung Cancer and Chest Tumours, Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw) and the Department of Internal Medicine, Pulmonary Diseases and Allergy, were enrolled. We conducted analyses of the clinical, psychological and socioeconomic factors of women with lung cancer treated in everyday practice, including a comparison with a group of men. Demographic data were collected from a self-administered questionnaire. We used the Perceived Stress Scale (PSS-10) and Acceptance of Illness Scale (AIS) questionnaires for psychological evaluation. (3) Results: A total of 100 patients with confirmed primary lung cancer with a history of treatment were enrolled in the study (50 women and 50 men). We found a significantly shorter history of smoking in the group of women; at the same time, there were no differences in the reported incidence of COPD. Despite comparable results to men on the psychological questionnaire (PSS-10, AIS), women more often reported a willingness to be supported by a psychologist or psychiatrist due to lung cancer. However, they did not decide to consult them more often than men. Immunotherapy was a significantly less frequently used method in women. (4) Conclusions: We should be more active in finding out the willingness to consult a psychologist or psychiatrist among women with lung cancer. The diagnosis of COPD should be considered more often among women due to the lack of differences in the reported incidence of COPD between men and women, despite a clear contrast in the number of pack-years.

show abstract

“…Data and clinical experience over the last 50 years have accumulated in psycho-oncology, as also confirmed by the global increase in psycho-oncology research. 1,2 Official documents from several institutional entities, 3,4 position statements of international societies and clinical guidelines and recommendations [5][6][7][8] have converged in underscoring the mandatory need for psycho-oncology in all cancer settings, from prevention to end-of-life care. Two decades ago, the International Psycho-Oncology Society (IPOS) Standard on Quality Cancer Care stated that psychosocial cancer care should be recognized as a universal human right; quality cancer care must integrate the psychosocial domain into routine care, and distress should be measured as the sixth vital sign.…”

Section: Introductionmentioning

confidence: 99%

Core‐curriculum in psycho‐oncology: Towards the certification of the psycho‐oncologist profession

Grassi,

Watson

2024

Psycho-Oncology

View full text Add to dashboard Cite

BackgroundIssues relating to certification of the Psycho‐oncology profession require clarification in order to provide high quality comprehensive psychosocial care within oncology. We conducted a survey identifying existing training, professional registration requirements and accreditation programs, at national levels, for the specialty of psycho‐oncology as well as the mandatory presence of this specialist in cancer teams.MethodsThis survey was conducted within the International Psycho‐Oncology Society Federation of psycho‐oncology societies and included representatives of each national federated society and some countries not belonging to the Federation. Survey questions were emailed requesting specific details, from the registered contact person, for each country, about psycho‐oncology training, professional registration and accreditation.ResultsOf 43 countries contacted (34 Federated and 9 non‐federated members), 39 replied and answered the questionnaire (90, 7%). Disparities were reported between countries, with details indicating differences from having no national program, to quite detailed and legally accredited requirements. The majority of countries had no formally recognized profession of “Psycho‐oncologist,” while some countries reported that it is mandatory (or recommended to have) a specialist in psycho‐oncology in cancer centers and, thus, that an accredited, nationally recognized and certified training in this specialty exists.ConclusionsThe study underlines the need to create a curriculum for the specialty (certification and accreditation) for the profession of psycho‐oncology. Given the lack of internationally recognized core standards, ideas and proposals for minimum standards of good care and the training required to deliver this, are explored to clarify who may use the designation “Clinical Psycho‐oncologist.”

show abstract

Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline

Cited by 31 publications

References 122 publications

Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study

Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study

Lung Cancer in Women—Sociodemographic, Clinical and Psychological Characteristics with Comparison to Men

Core‐curriculum in psycho‐oncology: Towards the certification of the psycho‐oncologist profession

Contact Info

Product

Resources

About